CN Stock MarketDetailed Quotes

002393 Tianjin Lisheng Pharmaceutical

Watchlist
  • 17.08
  • -0.51-2.90%
Not Open Jun 3 15:00 CST
4.41BMarket Cap11.76P/E (TTM)

Tianjin Lisheng Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2023/FY
Stock NameRevenueRatio
Tablet817.69M70.92%
Injection200.89M17.42%
Capsule89.36M7.75%
Other45.09M3.91%
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing1.15B100.00%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
North China552.77M47.94%
East China region224.86M19.50%
Central and southern region202.74M17.58%
Southwest area90.83M7.88%
Northwest region58.91M5.11%
Northeast area20.17M1.75%
Exit2.75M0.24%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg